ATE297895T1 - 4-pyridinyl-n-acyl-l-phenylalanine - Google Patents

4-pyridinyl-n-acyl-l-phenylalanine

Info

Publication number: ATE297895T1
Authority: AT; Austria
Prior art keywords: pyridinyl; phenylalanine; acyl
Prior art date: 1999-12-06

Application number

AT00985117T

Other languages

English (en)

Inventor

Gerald Lewis Kaplan

Achyutharao Sidduri

Jefferson Wright Tilley

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-12-06

Filing date

2000-11-29

Publication date

2005-07-15

2000-11-29 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2005-07-15 Application granted granted Critical

2005-07-15 Publication of ATE297895T1 publication Critical patent/ATE297895T1/de

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Rheumatology (AREA)
Pulmonology (AREA)
Neurology (AREA)
Pain & Pain Management (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyridine Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT00985117T 1999-12-06 2000-11-29 4-pyridinyl-n-acyl-l-phenylalanine ATE297895T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US16909099P	1999-12-06	1999-12-06
PCT/EP2000/011979 WO2001042215A1 (en)	1999-12-06	2000-11-29	4-pyridinyl-n-acyl-l-phenylalanines

Publications (1)

Publication Number	Publication Date
ATE297895T1 true ATE297895T1 (de)	2005-07-15

Family

ID=22614226

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT00985117T ATE297895T1 (de)	1999-12-06	2000-11-29	4-pyridinyl-n-acyl-l-phenylalanine

Country Status (33)

Country	Link
EP (1)	EP1244625B1 (de)
JP (2)	JP2003516392A (de)
KR (1)	KR100492111B1 (de)
CN (1)	CN1196682C (de)
AR (1)	AR031083A1 (de)
AT (1)	ATE297895T1 (de)
AU (1)	AU779063B2 (de)
BR (1)	BR0016172A (de)
CA (1)	CA2392566A1 (de)
CO (1)	CO5080771A1 (de)
CZ (1)	CZ20022352A3 (de)
DE (1)	DE60020883T2 (de)
DK (1)	DK1244625T3 (de)
ES (1)	ES2243335T3 (de)
GC (1)	GC0000214A (de)
HR (1)	HRP20020467A2 (de)
HU (1)	HUP0203735A3 (de)
IL (2)	IL149622A0 (de)
JO (1)	JO2281B1 (de)
MA (1)	MA26849A1 (de)
MX (1)	MXPA02005240A (de)
MY (1)	MY128003A (de)
NO (1)	NO322910B1 (de)
NZ (1)	NZ518888A (de)
PE (1)	PE20010960A1 (de)
PL (1)	PL364814A1 (de)
PT (1)	PT1244625E (de)
RU (1)	RU2270193C2 (de)
TW (1)	TWI276629B (de)
UY (1)	UY26470A1 (de)
WO (1)	WO2001042215A1 (de)
YU (1)	YU40502A (de)
ZA (1)	ZA200203762B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6960597B2 (en)	2000-06-30	2005-11-01	Orth-Mcneil Pharmaceutical, Inc.	Aza-bridged-bicyclic amino acid derivatives as α4 integrin antagonists
RU2286340C2 (ru)	2000-08-18	2006-10-27	Адзиномото Ко., Инк.	Новые производные фенилаланина
WO2002028830A1 (en) *	2000-09-29	2002-04-11	Ajinomoto Co.,Inc.	Novel phenylalanine derivatives
WO2003053926A1 (en)	2001-12-13	2003-07-03	Ajinomoto Co.,Inc.	Novel phenylalanine derivative
US7482366B2 (en)	2001-12-21	2009-01-27	X-Ceptor Therapeutics, Inc.	Modulators of LXR
AU2002351412B2 (en)	2001-12-21	2010-05-20	Exelixis Patent Company Llc	Modulators of LXR
EP1700850B1 (de)	2003-12-22	2015-07-15	Ajinomoto Co., Inc.	Phenylalaninderivat
US7618981B2 (en) *	2004-05-06	2009-11-17	Cytokinetics, Inc.	Imidazopyridinyl-benzamide anti-cancer agents
WO2006023396A2 (en) *	2004-08-16	2006-03-02	Merck & Co., Inc.	Vla-4 antagonists
JP4784224B2 (ja)	2004-09-24	2011-10-05	味の素株式会社	糖鎖転移方法および糖鎖転移酵素
WO2007100763A2 (en) *	2006-02-28	2007-09-07	Elan Pharmaceuticals, Inc.	Methods of treating inflammatory and autoimmune diseases with alpha-4 inhibitory compounds
AR060901A1 (es) *	2006-05-12	2008-07-23	Jerini Ag	Compuestos heterociclicos para la inhibicion de integrinas y uso de estos
EP2510941A3 (de)	2007-02-20	2013-01-23	Merrimack Pharmaceuticals, Inc.	Verfahren zur Behandlung von multipler Sklerose mittels Verabreichung eines alpha-Fetoproteins in Kombination mit einem Integrinantagonisten
PL2288715T3 (pl)	2008-04-11	2015-03-31	Merrimack Pharmaceuticals Inc	Łączniki będące albuminą surowicy ludzkiej i ich koniugaty
RU2012106074A (ru) *	2009-07-23	2013-08-27	Байер Кропсайенс Аг	Новые алкоксиеноны и енаминокетоны и способ их получения
US8877815B2 (en)	2010-11-16	2014-11-04	Novartis Ag	Substituted carbamoylcycloalkyl acetic acid derivatives as NEP
JP6159740B2 (ja) *	2012-01-27	2017-07-05	エフ．ホフマン−ラロシュアーゲーＦ．Ｈｏｆｆｍａｎｎ−ＬａＲｏｃｈｅＡｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ	Ｖｌａ−４を発現する細胞への標的化送達のためのインテグリンアンタゴニスト結合体
BR112015031040A8 (pt) *	2013-06-11	2018-01-02	Receptos Inc	Novos moduladores do receptor de glp-1
JP6820282B2 (ja)	2016-02-05	2021-01-27	Ｅａファーマ株式会社	スルホンアミド誘導体及びそれを含有する医薬組成物
ES3003232T3 (en)	2018-10-30	2025-03-10	Gilead Sciences Inc	Compounds for inhibition of alpha4beta7 integrin
EP3873900B1 (de)	2018-10-30	2025-01-08	Gilead Sciences, Inc.	Imidazo[1,2-a]pyridin-derivate als alpha4beta7 integrin-inhibitoren zur behandlung von entzündlichen erkrankungen
CA3115820A1 (en)	2018-10-30	2020-05-07	Gilead Sciences, Inc.	Compounds for inhibition of .alpha.4.beta.7 integrin
CN112969687B (zh)	2018-10-30	2024-08-23	吉利德科学公司	作为α4β7整合素抑制剂的喹啉衍生物
CA3148613A1 (en)	2019-08-14	2021-02-18	Gilead Sciences, Inc.	Phenylalanine derived compounds and their use as inhinitors of alpha 4 beta 7 integrin

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA848275B (en) *	1983-12-28	1985-08-28	Degussa	New piridine-2-ethers or pyridine-2-thioethers having a nitrogen-containing cycloaliphatic ring
AU726585B2 (en) *	1997-05-29	2000-11-09	Merck & Co., Inc.	Biarylalkanoic acids as cell adhesion inhibitors
EP1001764A4 (de) *	1997-05-29	2005-08-24	Merck & Co Inc	Heterozyklische amide als zelladhäsionshemmern
US6197794B1 (en) *	1998-01-08	2001-03-06	Celltech Therapeutics Limited	Phenylalanine derivatives
MY153569A (en) *	1998-01-20	2015-02-27	Mitsubishi Tanabe Pharma Corp	Inhibitors of ?4 mediated cell adhesion
US6329372B1 (en) *	1998-01-27	2001-12-11	Celltech Therapeutics Limited	Phenylalanine derivatives
WO1999043642A1 (en) *	1998-02-26	1999-09-02	Celltech Therapeutics Limited	Phenylalanine derivatives as inhibitors of alpha4 integrins
GB9811159D0 (en) *	1998-05-22	1998-07-22	Celltech Therapeutics Ltd	Chemical compounds
ES2220140T3 (es) *	1998-12-22	2004-12-01	Tanabe Seiyaku Co., Ltd.	Inhibidores de la adhesion mediada de celulas por alfa 4 beta 1 (a4b1).
HK1045495A1 (zh) *	1999-01-22	2002-11-29	依兰制药公司	抑制vla-4介导的白细胞粘着的多环化合物

2000
- 2000-11-29 HR HR20020467A patent/HRP20020467A2/xx not_active Application Discontinuation
- 2000-11-29 AU AU21639/01A patent/AU779063B2/en not_active Ceased
- 2000-11-29 DE DE60020883T patent/DE60020883T2/de not_active Expired - Lifetime
- 2000-11-29 EP EP00985117A patent/EP1244625B1/de not_active Expired - Lifetime
- 2000-11-29 BR BR0016172-1A patent/BR0016172A/pt not_active Application Discontinuation
- 2000-11-29 PL PL00364814A patent/PL364814A1/xx not_active Application Discontinuation
- 2000-11-29 YU YU40502A patent/YU40502A/sh unknown
- 2000-11-29 MX MXPA02005240A patent/MXPA02005240A/es active IP Right Grant
- 2000-11-29 NZ NZ518888A patent/NZ518888A/en unknown
- 2000-11-29 AT AT00985117T patent/ATE297895T1/de not_active IP Right Cessation
- 2000-11-29 DK DK00985117T patent/DK1244625T3/da active
- 2000-11-29 PT PT00985117T patent/PT1244625E/pt unknown
- 2000-11-29 JP JP2001543516A patent/JP2003516392A/ja active Pending
- 2000-11-29 CA CA002392566A patent/CA2392566A1/en not_active Abandoned
- 2000-11-29 IL IL14962200A patent/IL149622A0/xx active IP Right Grant
- 2000-11-29 CN CNB008164800A patent/CN1196682C/zh not_active Expired - Fee Related
- 2000-11-29 CZ CZ20022352A patent/CZ20022352A3/cs unknown
- 2000-11-29 HU HU0203735A patent/HUP0203735A3/hu unknown
- 2000-11-29 WO PCT/EP2000/011979 patent/WO2001042215A1/en not_active Ceased
- 2000-11-29 KR KR10-2002-7007201A patent/KR100492111B1/ko not_active Expired - Fee Related
- 2000-11-29 JO JO2000189A patent/JO2281B1/en active
- 2000-11-29 ES ES00985117T patent/ES2243335T3/es not_active Expired - Lifetime
- 2000-11-29 RU RU2002117419/04A patent/RU2270193C2/ru not_active IP Right Cessation
- 2000-12-02 GC GCP20001072 patent/GC0000214A/en active
- 2000-12-04 AR ARP000106416A patent/AR031083A1/es not_active Application Discontinuation
- 2000-12-04 MY MYPI20005689A patent/MY128003A/en unknown
- 2000-12-05 TW TW089125889A patent/TWI276629B/zh not_active IP Right Cessation
- 2000-12-05 UY UY26470A patent/UY26470A1/es not_active Application Discontinuation
- 2000-12-05 CO CO00092690A patent/CO5080771A1/es unknown
- 2000-12-06 PE PE2000001306A patent/PE20010960A1/es not_active Application Discontinuation
2002
- 2002-05-10 ZA ZA200203762A patent/ZA200203762B/xx unknown
- 2002-05-13 IL IL149622A patent/IL149622A/en not_active IP Right Cessation
- 2002-06-05 MA MA26672A patent/MA26849A1/fr unknown
- 2002-06-05 NO NO20022650A patent/NO322910B1/no unknown
2007
- 2007-10-05 JP JP2007262543A patent/JP2008094842A/ja active Pending

Also Published As

Publication number	Publication date
HRP20020467A2 (en)	2004-04-30
JP2008094842A (ja)	2008-04-24
YU40502A (sh)	2005-03-15
CN1196682C (zh)	2005-04-13
GC0000214A (en)	2006-03-29
WO2001042215A1 (en)	2001-06-14
CN1402709A (zh)	2003-03-12
CZ20022352A3 (cs)	2003-05-14
TWI276629B (en)	2007-03-21
KR20020060256A (ko)	2002-07-16
BR0016172A (pt)	2002-08-20
MXPA02005240A (es)	2002-11-07
EP1244625B1 (de)	2005-06-15
KR100492111B1 (ko)	2005-06-01
RU2270193C2 (ru)	2006-02-20
AU2163901A (en)	2001-06-18
JO2281B1 (en)	2005-09-12
PT1244625E (pt)	2005-09-30
CO5080771A1 (es)	2001-09-25
DK1244625T3 (da)	2005-10-10
UY26470A1 (es)	2001-05-31
HUP0203735A2 (hu)	2003-03-28
AU779063B2 (en)	2005-01-06
DE60020883D1 (de)	2005-07-21
AR031083A1 (es)	2003-09-10
NO20022650L (no)	2002-06-05
NZ518888A (en)	2004-02-27
NO322910B1 (no)	2006-12-18
HK1053470A1 (en)	2003-10-24
JP2003516392A (ja)	2003-05-13
CA2392566A1 (en)	2001-06-14
HUP0203735A3 (en)	2005-03-29
NO20022650D0 (no)	2002-06-05
IL149622A (en)	2006-12-10
MY128003A (en)	2007-01-31
IL149622A0 (en)	2002-11-10
DE60020883T2 (de)	2006-03-23
MA26849A1 (fr)	2004-12-20
EP1244625A1 (de)	2002-10-02
PL364814A1 (en)	2004-12-13
ES2243335T3 (es)	2005-12-01
PE20010960A1 (es)	2001-09-22
ZA200203762B (en)	2004-01-28

Publication	Publication Date	Title
DE50010505D1 (de)	2005-07-14	Gurtaufrollersystem
DE122007000064I1 (de)	2008-01-03	Erythropoietinkonjugate
DE10084676T1 (de)	2003-04-30	Einmallanzettvorrichtung
DE50002834D1 (de)	2003-08-14	Handstempel
DE60001283D1 (de)	2003-03-06	Celluloseetherfilme
ATE357433T1 (de)	2007-04-15	4-pyrimidinyl-n-acyl-l-phenylanine
DE60020883D1 (de)	2005-07-21	4-pyridinyl-n-acyl-l-phenylalanine
DE60001894D1 (de)	2003-05-08	Busschienenverbindungsstruktur
DE50009570D1 (de)	2005-03-31	Wechselcorrugator
DE59909346D1 (de)	2004-06-03	Zylinderkopfdichtung
DE60001649D1 (de)	2003-04-17	Ziprasidonsuspension
DE59910286D1 (de)	2004-09-23	Kniehebel-spannvorrichtung
DE50008613D1 (de)	2004-12-16	Sicherungsring
DE50006899D1 (de)	2004-07-29	Antistatikum
DE10085008T1 (de)	2002-10-10	Oberflächenbehandlungsdüse
DE50012482D1 (de)	2006-05-18	Tibiamarknagel
DE50003660D1 (de)	2003-10-16	Diacylhydrazinderivate
DE60001471D1 (de)	2003-04-03	4-Hydroxyisothiazolverbindungen
DE59906520D1 (de)	2003-09-11	Exzenterzahnradgetriebe
DE50006013D1 (de)	2004-05-13	Anschlagpuffer
DE19983890T1 (de)	2002-03-07	Ventiltaktgebungsjustiereinrichtung
DE50006759D1 (de)	2004-07-15	Piperidinalkohole
ATE440824T1 (de)	2009-09-15	Nitro-sulfobenzamide
DE50009208D1 (de)	2005-02-17	Hydroxyphenylvinylthiazole
ATE269311T1 (de)	2004-07-15	Benzoylpyridazine

Legal Events

Date	Code	Title	Description
2006-02-15	UEP	Publication of translation of european patent specification	Ref document number: 1244625 Country of ref document: EP
2009-08-15	REN	Ceased due to non-payment of the annual fee

Date

Code

Title

Description

2006-02-15

UEP

Publication of translation of european patent specification

Ref document number: 1244625

Country of ref document: EP

2009-08-15

REN

Ceased due to non-payment of the annual fee